NDC product
Cetirizine Hydrochloride Tablets, 10 mg
NDC 25000-220 · MARKSANS PHARMA LIMITED
Key facts
| Product NDC | 25000-220 |
|---|---|
| Proprietary name | Cetirizine Hydrochloride Tablets, 10 mg |
| Nonproprietary name | Cetirizine Hydrochloride |
| Substances | CETIRIZINE HYDROCHLORIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | MARKSANS PHARMA LIMITED |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA078933 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| Marketing start | Jan 13, 2022 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: